Iterum Therapeutics plc
(NASDAQ: ITRM)

Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.

0.537

+0.097 (+22.05%)
Range 0.411 - 0.544   (32.36%)
Open 0.411
Previous Close 0.440
Bid Price 1.150
Bid Volume 8
Ask Price 1.180
Ask Volume 12
Volume 902,999
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:06.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis